Previous findings have confirmed that miR-20a can inhibit E2F1 directly, which is a transcription factor associated with the lung cancer cell growth [32], thus making miR-20a helpful for the early diagnosis of NSCLC. Here, E2F1 is linked to non-small cell lung carcinoma.